查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球传染病诊断市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1342965

全球传染病诊断市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Infectious Respiratory Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

全球传染病诊断市场需求预计将从 2022 年的 659.2 亿美元增至 2030 年的近 854.1 亿美元，2023-2030 年研究期间复合年增长率为 2.92%。

呼吸道传染病是由病毒、细菌或其他病原微生物引起的。当人打喷嚏、咳嗽、说话或大笑时，可感染呼吸系统的微生物会通过唾液和粘液（也称为呼吸道分泌物）迅速传播。一些常见的传染性呼吸道疾病有流感、麻疹、肺结核、百日咳、风疹等。

市场动态：

呼吸道疾病的患病率不断上升、先进分子生物学技术的使用不断增加、老年人口不断增加，以及政府和低调组​​织为降低传染病风险而采取的倡议，推动了传染性呼吸道疾病诊断市场的发展。此外，自检产品和护理点产品的使用增加将促进市场增长。为了满足对传染病诊断的诊断和耗材日益增长的需求，创新技术的发展不断发展，这是推动呼吸道疾病诊断市场增长的另一个因素。肺部疾病（包括结核病和肺炎）以及其他慢性阻塞性肺部疾病（如慢性支气管炎、肺气肿和哮喘）病例的激增将促进市场增长。此外，对检测下呼吸道传染病的诊断测试和工具的需求不断增长将促进市场增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球传染性呼吸道疾病诊断市场的每个细分市场进行了包容性评估。传染性呼吸道疾病诊断行业的增长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的传染病诊断市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。传染性呼吸道疾病诊断市场的主要参与者包括 Abbott、Thermo Fisher Scientific Inc.、Koninklijke Philips NV、F. Hoffmann-La Roche Ltd.、bioMerieux SA、BD、Quidel Corporation、QIAGEN、Danaher、Siemens Healthcare GmbH。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：传染性呼吸道疾病诊断 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 行业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按产品类型
    • 按样本类型进行的市场吸引力分析
    • 市场吸引力分析：按应用分类
    • 按技术分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原料厂商清单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直效行销
    • 间接营销
    • 营销渠道发展趋势

5 COVID-19 爆发的影响分析

第 6 章：全球传染性呼吸道疾病诊断市场分析：按产品类型

  • 概述：按产品类型
  • 历史和预测数据
  • 分析：按产品类型
  • 仪器（成像测试、呼吸测量设备、其他仪器）
  • 耗材
  • 服务

第 7 章：全球传染性呼吸道疾病诊断市场分析：按样本类型

  • 按样本类型概述
  • 历史和预测数据
  • 按样本类型分析
  • 唾液
  • 鼻咽拭子 (NPS)
  • 前鼻区
  • 血
  • 其他的

第 8 章：全球传染性呼吸道疾病诊断市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 新冠肺炎
  • 流感
  • RSV（呼吸道合胞病毒）
  • 结核
  • 链球菌检测
  • 其他呼吸道疾病检测

第 9 章：全球传染性呼吸道疾病诊断市场分析：按技术分类

  • 按技术概述
  • 历史和预测数据
  • 按技术分析
  • 免疫分析
  • 分子诊断
  • 微生物学
  • 其他技术

第 10 章：全球传染性呼吸道疾病诊断市场分析：按最终用途分类

  • 按最终用途分類的概述
  • 历史和预测数据
  • 按最终用途分析
  • 医院
  • 诊断实验室
  • 医生办公室
  • 其他最终用户

第 11 章：全球传染性呼吸道疾病诊断市场分析：按地理位置

  • 顶级公司股票分析
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家/地区销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家/地区销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家/地区销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 12 章：传染性呼吸系统疾病诊断公司的竞争格局

  • 传染病诊断市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 13 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Abbott
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Koninklijke Philips NV
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • bioMerieux SA
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BD
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Quidel Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • QIAGEN
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Danaher
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Siemens Healthcare GmbH
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

Product Code: VMR11219207

The global demand for Infectious Respiratory Disease Diagnostics Market is presumed to reach the market size of nearly USD 85.41 BN by 2030 from USD 65.92 BN in 2022 with a CAGR of 2.92% under the study period 2023 - 2030.

Respiratory infectious diseases are caused by viruses, bacteria, or other pathogenic microbes. Microbes that can infect the respiratory system are rapidly spread through saliva & mucus (also referred to as respiratory secretions) when a person sneezes, coughs, talks or laughs. Some common infectious respiratory diseases are influenza, measles, tuberculosis, pertussis, rubella, etc.

MARKET DYNAMICS:

The market for infectious respiratory disease diagnostics is driven by an increasing prevalence of respiratory diseases, increasing use of advanced molecular biology techniques, a rising elderly population, and initiatives taken by the government and low-profile organizations to decrease the risk of infectious diseases. Moreover, increasing usage of self-testing products & point of care products will flourish the market growth. The rise in the development of innovative techniques for meeting the increasing demand for diagnostics & consumables for the diagnosis of infectious diseases is another factor driving the growth of the respiratory disease diagnostics market. The surge in cases of lung diseases, including tuberculosis & pneumonia and other chronic obstructive pulmonary disorders like chronic bronchitis, emphysema, and asthma, will foster market growth. Furthermore, rising demand for diagnostic tests & tools to detect lower respiratory infectious disease will augment the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of infectious respiratory disease diagnostics. The growth and trends of infectious respiratory disease diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the infectious respiratory disease diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
  • Consumables
  • Services

By Sample Type

  • Saliva
  • Nasopharyngeal Swabs (NPS)
  • Anterior Nasal Region
  • Blood
  • Others

By Application

  • COVID-19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
  • Tuberculosis
  • Streptococcus Testing
  • Other Respiratory Disease Testing

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Other Technologies

By End-Use

  • Hospitals
  • Diagnostic Laboratories
  • Physician Offices
  • Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Infectious Respiratory Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the infectious respiratory disease diagnostics market include Abbott, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., bioMerieux SA, BD, Quidel Corporation, QIAGEN, Danaher, Siemens Healthcare GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Historic and Forecast Sales by Regions
  • 6.5 Consumables Historic and Forecast Sales by Regions
  • 6.6 Services Historic and Forecast Sales by Regions

7 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY SAMPLE TYPE

  • 7.1 Overview by Sample Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Sample Type
  • 7.4 Saliva Historic and Forecast Sales by Regions
  • 7.5 Nasopharyngeal Swabs (NPS) Historic and Forecast Sales by Regions
  • 7.6 Anterior Nasal Region Historic and Forecast Sales by Regions
  • 7.7 Blood Historic and Forecast Sales by Regions
  • 7.8 Others Historic and Forecast Sales by Regions

8 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 COVID-19 Historic and Forecast Sales by Regions
  • 8.5 Influenza Historic and Forecast Sales by Regions
  • 8.6 RSV (Respiratory Syncytial Virus) Historic and Forecast Sales by Regions
  • 8.7 Tuberculosis Historic and Forecast Sales by Regions
  • 8.8 Streptococcus Testing Historic and Forecast Sales by Regions
  • 8.9 Other Respiratory Disease Testing Historic and Forecast Sales by Regions

9 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 9.1 Overview by Technology
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Technology
  • 9.4 Immunoassay Historic and Forecast Sales by Regions
  • 9.5 Molecular Diagnostics Historic and Forecast Sales by Regions
  • 9.6 Microbiology Historic and Forecast Sales by Regions
  • 9.7 Other technologies Historic and Forecast Sales by Regions

10 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 10.1 Overview by End-use
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End-use
  • 10.4 Hospitals Historic and Forecast Sales by Regions
  • 10.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.6 Physician Offices Historic and Forecast Sales by Regions
  • 10.7 Other End Users Historic and Forecast Sales by Regions

11 . GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS COMPANIES

  • 12.1. Infectious Respiratory Disease Diagnostics Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Abbott
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Thermo Fisher Scientific Inc.
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Koninklijke Philips N.V.
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. F. Hoffmann-La Roche Ltd.
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. bioMerieux SA
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. BD
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Quidel Corporation
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. QIAGEN
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Danaher
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. Siemens Healthcare GmbH
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Nasopharyngeal Swabs (NPS) Market Sales by Geography (USD MN)
  • Anterior Nasal Region Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • COVID-19 Market Sales by Geography (USD MN)
  • Influenza Market Sales by Geography (USD MN)
  • RSV (Respiratory Syncytial Virus) Market Sales by Geography (USD MN)
  • Tuberculosis Market Sales by Geography (USD MN)
  • Streptococcus Testing Market Sales by Geography (USD MN)
  • Other Respiratory Disease Testing Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Other technologies Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Physician Offices Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Infectious Respiratory Disease Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Infectious Respiratory Disease Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Infectious Respiratory Disease Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Sample Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Sample Type (USD MN)
  • Saliva Market Sales by Geography (USD MN)
  • Nasopharyngeal Swabs (NPS) Market Sales by Geography (USD MN)
  • Anterior Nasal Region Market Sales by Geography (USD MN)
  • Blood Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • COVID-19 Market Sales by Geography (USD MN)
  • Influenza Market Sales by Geography (USD MN)
  • RSV (Respiratory Syncytial Virus) Market Sales by Geography (USD MN)
  • Tuberculosis Market Sales by Geography (USD MN)
  • Streptococcus Testing Market Sales by Geography (USD MN)
  • Other Respiratory Disease Testing Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Molecular Diagnostics Market Sales by Geography (USD MN)
  • Microbiology Market Sales by Geography (USD MN)
  • Other technologies Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Physician Offices Market Sales by Geography (USD MN)
  • Other End Users Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.